- Home
- ENSC vs AMZE Comparison
ENSC vs AMZE Comparison
Compare ENSC & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- AMZE
- Stock Information
- Founded
- ENSC 2003
- AMZE 2019
- Country
- ENSC United States
- AMZE United States
- Employees
- ENSC N/A
- AMZE N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- ENSC Health Care
- AMZE Consumer Staples
- Exchange
- ENSC Nasdaq
- AMZE Nasdaq
- Market Cap
- ENSC 4.9M
- AMZE 5.2M
- IPO Year
- ENSC N/A
- AMZE 2021
- Fundamental
- Price
- ENSC $2.22
- AMZE $10.00
- Analyst Decision
- ENSC
- AMZE
- Analyst Count
- ENSC 0
- AMZE 0
- Target Price
- ENSC N/A
- AMZE N/A
- AVG Volume (30 Days)
- ENSC 230.3K
- AMZE 71.2K
- Earning Date
- ENSC 08-13-2025
- AMZE 08-13-2025
- Dividend Yield
- ENSC N/A
- AMZE N/A
- EPS Growth
- ENSC N/A
- AMZE N/A
- EPS
- ENSC N/A
- AMZE N/A
- Revenue
- ENSC $6,224,081.00
- AMZE $254,711.00
- Revenue This Year
- ENSC N/A
- AMZE N/A
- Revenue Next Year
- ENSC $1,381.48
- AMZE N/A
- P/E Ratio
- ENSC N/A
- AMZE N/A
- Revenue Growth
- ENSC 256.35
- AMZE N/A
- 52 Week Low
- ENSC $1.62
- AMZE $5.78
- 52 Week High
- ENSC $14.67
- AMZE $28.72
- Technical
- Relative Strength Index (RSI)
- ENSC 49.53
- AMZE N/A
- Support Level
- ENSC $2.02
- AMZE N/A
- Resistance Level
- ENSC $2.30
- AMZE N/A
- Average True Range (ATR)
- ENSC 0.14
- AMZE 0.00
- MACD
- ENSC 0.02
- AMZE 0.00
- Stochastic Oscillator
- ENSC 43.40
- AMZE 0.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.